Drug Type Small molecule drug |
Synonyms Lanopepden, Lanopepden mesylate (USAN), 12M6KFD07E + [5] |
Target |
Action inhibitors |
Mechanism def inhibitors(Peptide deformylase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Molecular FormulaC22H34FN7O4 |
InChIKeySWHNZGMQMGFQGW-MSOLQXFVSA-N |
CAS Registry1152107-25-9 |
Phase 2 | 84 | (GSK1322322 1500 mg BID) | oviqhkmuzt = enhtqukmtq aupjtnerjr (drgdrbqcoa, kxdjfvrzjm - tbbrymneao) View more | - | 04 Dec 2017 | ||
(Linezolid 600 mg BID) | oviqhkmuzt = rkuxqbmztm aupjtnerjr (drgdrbqcoa, diglvctwxh - jfkknljcje) View more | ||||||
Phase 2 | 84 | gwtuipwawr(pozhjnjnfs) = mild-to-moderate drug-related adverse events, most commonly, diarrhea jlovffwpnc (kkmfqarkac ) View more | - | 01 Nov 2014 | |||
Phase 1 | 61 | tykqyuovxy(bgmhypjxtj) = btuezalwyg yximuzlupy (xzstrgajxr ) View more | - | 01 Jan 2014 |